131 related articles for article (PubMed ID: 37712977)
1. Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
Panchawagh S; Bohdana D; Kuwana M; Yoshida A; Yomono K; Pauling JD; Makol A; Kadam E; Day J; Chatterjee T; Katchamart W; Goo PA; Nikiphorou E; Sen P; Dey D; Cavagna L; Gutiérrez CET; Agarwal V; Milchert M; Ziade N; Distler O; Group CS; Chinoy H; Aggarwal R; Gupta L; Agarwal V
Rheumatol Int; 2023 Dec; 43(12):2211-2220. PubMed ID: 37712977
[TBL] [Abstract][Full Text] [Related]
2. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Doskaliuk B; Ravichandran N; Sen P; Day J; Joshi M; Nune A; Nikiphorou E; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Jagtap K; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Chen YM; Makol A; Agarwal V; Patel A; Pauling JD; Wincup C; Barman B; Tehozol EAZ; Serrano JR; La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Hoff LS; Kibbi LE; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatol Int; 2023 Sep; 43(9):1651-1664. PubMed ID: 37351634
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
Sen P; Ravichandran N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2022 Dec; 62(1):65-76. PubMed ID: 35713499
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey.
Naveen R; Thakare DR; Kuwana M; Pauling JD; Day J; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; ; Aggarwal R; Gupta L; Agarwal V; Makol A
Rheumatol Int; 2023 Jul; 43(7):1265-1275. PubMed ID: 37000295
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey.
Hoff LS; Ravichandran N; Shinjo SK; Day J; Sen P; Junior JG; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Milchert M; Makol A; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Cansu DÜ; Traboco L; Wibowo SAK; Tehozol EAZ; Serrano JR; La Torre IG; Wincup C; Pauling JD; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2023 Jan; 43(1):47-58. PubMed ID: 36271958
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of emerging new autoimmune diseases after COVID-19 vaccination: A sub-study by the COVAD group.
Shumnalieva R; Ravichandran N; Hannah J; Javaid M; Darooka N; Roy D; Gonzalez DE; Velikova T; Milchert M; Kuwana M; Joshi M; Gracia-Ramos AE; Boyd P; Yaadav P; Cheng K; Kobert L; Cavagna L; Sen P; Day J; Makol A; Gutiérrez CET; Caballero-Uribe CV; Saha S; Parodis I; Dey D; Nikiphorou E; Distler O; Kadam E; Tan AL; Shinjo SK; Ziade N; Knitza J; Chinoy H; Aggarwal R; Agarwal V; Gupta L;
Int J Rheum Dis; 2024 May; 27(5):e15178. PubMed ID: 38742751
[TBL] [Abstract][Full Text] [Related]
8. High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey.
Grignaschi S; Kim M; Zanframundo G; Ravichandran N; Lilleker JB; Sen P; Joshi M; Agarwal V; Kardes S; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Chatterjee T; Tan AL; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Nune A; Distler O; Chinoy H; Cavagna L; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2023 Sep; 43(9):1637-1649. PubMed ID: 37314497
[TBL] [Abstract][Full Text] [Related]
9. Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
Ahmed S; Gupta L; Kuwana M; Pauling JD; Day J; Ravichandran N; Joshi M; Parodis I; Sen P; Jagtap K; Nikiphorou E; Saha S; Agarwal V; Chatterjee T; Lilleker JB; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Wibowo SAK; ; Chinoy H; Aggarwal R; Agarwal V; Makol A
Rheumatol Int; 2024 Jan; 44(1):89-97. PubMed ID: 37668836
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
Naveen R; Parodis I; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Nune A; Shinjo SK; Salim B; Ziade N; Velikova T; Edgar Gracia-Ramos A; Saavedra MA; Day J; Makol A; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L; Nikiphorou E;
Rheumatology (Oxford); 2023 Jul; 62(7):2366-2376. PubMed ID: 36315075
[TBL] [Abstract][Full Text] [Related]
11. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
Sen P; R N; Houshmand N; Moghadam Kia S; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; ; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Oct; 62(10):3291-3301. PubMed ID: 36734536
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccination-Related Delayed Adverse Events among Patients with Systemic Lupus Erythematosus.
Dey M; Doskaliuk B; Lindblom J; Nikiphorou E; Wincup C; Fathima M; Saha S; Shaharir SS; Katchamart W; Goo PA; Traboco L; Chen YM; Kadam E; Lilleker JB; Nune A; Pauling JD; Agarwal V; Dey D; Toro Gutierrez CE; Caballero CV; Chinoy H; Covad Study Group ; Aggarwal R; Agarwal V; Gupta L; Parodis I
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137611
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.
Naveen R; Nikiphorou E; Joshi M; Sen P; Lindblom J; Agarwal V; Lilleker JB; Tan AL; Salim B; Ziade N; Velikova T; Gracia-Ramos AE; Kuwana M; Day J; Makol A; Distler O; Chinoy H; Traboco LS; Wibowo SAK; Tehozol EAZ; Serrano JR; García-De La Torre I; ; Aggarwal R; Gupta L; Agarwal V; Parodis I
Rheumatology (Oxford); 2023 Jul; 62(7):2453-2463. PubMed ID: 36413073
[TBL] [Abstract][Full Text] [Related]
14. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
15. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Dec; 62(12):3838-3848. PubMed ID: 36961331
[TBL] [Abstract][Full Text] [Related]
16. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.
Ferri C; Raimondo V; Giuggioli D; Gragnani L; Lorini S; Dagna L; Bosello SL; Foti R; Riccieri V; Guiducci S; Cuomo G; Tavoni A; De Angelis R; Cacciapaglia F; Zanatta E; Cozzi F; Murdaca G; Cavazzana I; Romeo N; Codullo V; Pellegrini R; Varcasia G; De Santis M; Selmi C; Abignano G; Caminiti M; L'Andolina M; Olivo D; Lubrano E; Spinella A; Lumetti F; De Luca G; Ruscitti P; Urraro T; Visentini M; Bellando-Randone S; Visalli E; Testa D; Sciascia G; Masini F; Pellegrino G; Saccon F; Balestri E; Elia G; Ferrari SM; Tonutti A; Dall'Ara F; Pagano Mariano G; Pettiti G; Zanframundo G; Brittelli R; Aiello V; Dal Bosco Y; Foti R; Di Cola I; Scorpiniti D; Fusaro E; Ferrari T; Gigliotti P; Campochiaro C; Francioso F; Iandoli C; Caira V; Zignego AL; D'Angelo S; Franceschini F; Matucci-Cerinic M; Giacomelli R; Doria A; Santini SA; Fallahi P; Iannone F; Antonelli A;
J Transl Autoimmun; 2023 Dec; 7():100212. PubMed ID: 37854035
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study.
Andreoli L; Lini D; Schreiber K; Parodis I; Sen P; Ravichandran N; Day J; Joshi M; Jagtap K; Nune A; Nikiphorou E; Agarwal V; Saha S; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Serrano JR; De La Torre IG; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akarawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Shaharir SS; Hasan ATMT; Dey D; Toro Gutiérrez CE; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2024 May; 63(5):1341-1351. PubMed ID: 37505460
[TBL] [Abstract][Full Text] [Related]
18. Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study.
Chatterjee T; Ravichandran N; Nair N; Gracia-Ramos AE; Barman B; Sen P; Joshi M; Saha S; Nune A; Pande AKR; Velikova T; Parodis I; Tan AL; Shinjo SK; Boro H; Agarwal V; Aggarwal R; Gupta L;
J Diabetes Investig; 2024 Jan; 15(1):131-138. PubMed ID: 37697820
[TBL] [Abstract][Full Text] [Related]
19. Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland.
Paczkowska A; Hoffmann K; Michalak M; Hans-Wytrychowska A; Bryl W; Kopciuch D; Zaprutko T; Ratajczak P; Nowakowska E; Kus K
Vaccines (Basel); 2022 Mar; 10(3):. PubMed ID: 35335066
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Panchawagh S; Ravichandran N; Barman B; Nune A; Javaid M; Gracia-Ramos AE; Day J; Joshi M; Kuwana M; Saha S; Pande AR; Caballero-Uribe CV; Velikova T; Parodis I; Knitza J; Kadam E; Tan AL; Shinjo SK; Boro H; ; Aggarwal R; Agarwal V; Chatterjee T; Gupta L
Rheumatol Int; 2024 Jan; 44(1):73-80. PubMed ID: 38060005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
